BMW i Ventures, Dell Technologies Capital and Robert Bosch Venture Capital are in line to exit the manufactiuring services marketplace, which has filed for a $100m offering.

The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.

Qualcomm Ventures and Samsung Ventures are in line for exits as the cybersecurity technology provider - valued at $3bn as of November - looks to float.

WuXi AppTec, Fosun, Sinopharm and Humanwell have all invested in the oncology treatment developer, which has filed to raise up to $100m.

The LinkedIn data software spinoff was valued at $4.5bn in its last funding round and has set a $100m placeholder target for the offering.

The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.

The electronics parts recycling service also known as AtRenew has filed to list in a US offering that would enable strategic partner JD.com and its JD Logistics unit to exit.

Bayer and Fujifilm could exit the oncology therapy developer through an initial public offering with a $100m placeholder target.

General Motors and Palantir will support a $100m PIPE deal in connection with a reverse takeover for the vehicular data platform developer.

AP Moller and Norlys could exit the hydrogen production technology developer in a Nasdaq Copenhagen offering expected to raise $164m.